ARCT | Arcturus Therapeutics HoldingsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$9.54
+$0.05 (+0.53%)

Arcturus Therapeutics Holdings (ARCT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.

The 50 SMA has sat above the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits between the 50 and the 200; on the 4-hour it is below both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
between the two $9.54 vs 50 $13.44 / 200 $9.02
Projection
No cross projected
Test
No active test
Last cross
Golden cross 26 Aug 2026 ยท projected 12 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $11.03 vs 50 $8.61 / 200 $18.85
Projection
No cross projected
Test
No active test
Last cross
No cross on record

Cross history

22
crosses on record since 2021
11 golden11 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
26 Aug 2026Golden moderatedaily12 bars outNot tested
25 Aug 2026Golden4-hour29 bars outNot tested
10 Jun 2026Death4-hour8 bars out1 bar cross test
20 Mar 2026Golden4-hour2 bars out1 bar cross test
1 Dec 2025Death steepdaily29 bars outNot tested

About ARCT

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$9.4M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.